35 patents currently held
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2035. from the record
Of the 9 now held by other companies, 9 name Cardiovascular Systems Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2035
Next term end
18
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2038 · High confidence
Also notable
Ends Feb 2038 · High confidence
Also notable
Ends Sep 2037 · High confidence
Also notable
Ends Apr 2037 · High confidence
Also notable
Ends Nov 2035 · High confidence
Also notable
Ends Oct 2038 · High confidence
Also notable
Ends May 2036 · High confidence
Also notable
Ends Aug 2040 · High confidence
Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems
US 10,792,422
The most cited patent in this portfolio, cited by 245 later US patents, top 1% of utility patents granted in 2020 in our data. Protection runs to 2038.
Responsive Whole Patient Care Compression Therapy and Treatment System
US 11,413,213
Cited by 24 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2038.
Robotically Augmented Catheter Manipulation Handle
US 10,675,442
Cited by 60 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2037.
Wearable Active-Compression Therapy and Treatment System
US 10,492,978
Cited by 27 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2037.
Pneumatic Distribution System Using Shared Pump Plenum
US 10,087,925
Cited by 16 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Temporary Pacing Lead
US 10,773,076
A family of 5 related applications built on the 2020 grant. Protection runs to 2038.
Canted Off-Axis Driver for Quiet Pneumatic Pumping
US 9,920,753
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2036.
Lead for the Temporary Stimulation of a Peripheral Nerve
US 11,446,485
Granted 2022. Computed term ends 2040.
Formerly held, still cited
Notable
Ends Feb 2042 · High confidence
Cited by 7 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2042.
now held by Cardiovascular Systems, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Feb 1 to 8, 2027 · next Feb 1
- 1 fee due Jun 3, 2027The maintenance fee for Wearable Active-Compression Therapy and Treatment System (US 10,492,978) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Lead for the Temporary Stimulation of a Peripheral Nerve (US 11,883,651) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Aug 20, 2027The maintenance fee for Valve Actuation System Through Permanent Magnet Use (US 11,906,070) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 1 fee due Sep 5, 2027The maintenance fee for Robotically Augmented Catheter Manipulation Handle (US 11,918,763) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Solenoid Operated Valve with Flux Density Concentration Ring and Molded-In Valve Seat (US 10,619,755) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 5 of the patents on this record were granted since Aug 21, 2026
What they patent
The largest of its 18 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Conductive Band for Intravascular Lithotripsy | 4 in force | to Sep 2041 |
| Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems | 4 in force | to Aug 2038 |
| Self-Validating Module for Software Control of Medical Devices | 3 in force | to Apr 2040 |
| Temporary Pacing Lead | 3 in force | to Oct 2038 |
| Robotically Augmented Catheter Manipulation Handle | 3 in force | to Sep 2037 |
| Wearable Active-Compression Therapy and Treatment System | 3 in force | to Apr 2037 |
| Lead for the Temporary Stimulation of a Peripheral Nerve | 2 in force | to Aug 2040 |
| Responsive Whole Patient Care Compression Therapy and Treatment System | 2 in force | to Feb 2038 |
| Canted Off-Axis Driver for Quiet Pneumatic Pumping | 2 in force | to Jul 2036 |
| Steerable Tip Catheter with Automatic Tension Apparatus | 1 in force | to Feb 2045 |
| Cell Culture System with Controlled Gas Transfer Boundary Conditions | 1 in force | to Oct 2042 |
| Valve Actuation System Through Permanent Magnet Use | 1 in force | to May 2042 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,048,832 | Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems In force · High confidence | In force | High confidence | |
| US 12,691,224 | Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems In force · High confidence | In force | High confidence | |
| US 10,087,925 | Pneumatic Distribution System Using Shared Pump Plenum In force · High confidence | In force | High confidence | |
| US 11,638,677 | Wearable Active-Compression Therapy and Treatment In force · Low confidence | In force | Low confidence | |
| US 11,642,273 | Responsive Whole Patient Care Compression Therapy and Treatment System In force · Medium confidence | In force | Medium confidence | |
| US 9,920,753 | Canted Off-Axis Driver for Quiet Pneumatic Pumping In force · High confidence | In force | High confidence | |
| US 9,822,773 | Durable Canted Off-Axis Driver for Quiet Pneumatic Pumping In force · High confidence | In force | High confidence | |
| US 11,253,419 | Wearable Active-Compression Therapy and Treatment In force · High confidence | In force | High confidence | |
| US 11,628,253 | Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems In force · High confidence | In force | High confidence | |
| US 10,492,978 | Wearable Active-Compression Therapy and Treatment System In force · High confidence | In force | High confidence |
Also on record, not counted in the 35: 9 patents in force now held by others · 1 patent ended · 12 applications pending · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.